18-month Study of Long-term Efficacy & Safety of Safinamide as add-on Therapy in Patients With Mid-late Stage PD
Clinical trial NCT01286935 · COMPLETED
Trial details
- NCT number
- NCT01286935
- Sponsor
- Newron Pharmaceuticals SPA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2010-04-01
- Enrollment
- 544
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.